Takeda and Iambic announce $1.7bn deal to advance small molecule programmes

​Takeda has entered into a multi-year partnership to utilise Iambic’s AI drug discovery models for advancing small molecule programmes, in a deal that could exceed $1.7bn.

The post Takeda and Iambic announce $1.7bn deal to advance small molecule programmes appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.